Study S000864

Comparison of Exenatide, Insulin or Pioglitazone on Glycaemic Control and β-cell Function in Drug-naïve Type 2 Diabetic Patients: A Multicentre Randomized Parallel-group Trial

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT01147627
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 416
Start: 2010-08
Primary completion: 2012-08
Lead sponsor: Sun Yat-sen University
Conditions: Diabetes Mellitus, Type 2; Newly Diagnosed
Interventions: DRUG:exenatide injection; DRUG:Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R; DRUG:Pioglitazone
Results posted: TRUE

Registered primary outcomes

the Comparison Between Treatment Groups of the Changes From Baseline in HbA1c at 48 Weeks [48 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.